Triple Jump
Triple Jump is an impact-focused investment manager founded in 2006. They manage or advise funds, portfolios, and mandates that create a positive impact in emerging economies while generating healthy financial returns. Their work revolves around five main development themes: Financial Inclusion, financing Small and Medium Enterprises (SMEs), affordable housing, access to clean energy, and climate and nature. They aim to contribute to a more responsible and inclusive financial sector. Triple Jump uses various instruments such as private debt, equity, mezzanine, and fund investments, coupled with technical assistance and advisory services to its investees, to deliver environmental, social, and financial returns. They emphasize a global network to quickly respond to client needs and better understand the environments in which they operate, and a local presence in investment markets to facilitate lasting relationships with clients and investees. Triple Jump's approach combines financial investment with a deep commitment to creating positive social and environmental outcomes. This is reflected in their impact metrics, such as the number of clients reached, jobs supported, CO2 emissions avoided, and technical assistance projects completed. They target underserved markets and populations, as evidenced by the percentage of rural and women clients reached. Their investment strategy is guided by a rigorous understanding of the challenges and opportunities in emerging markets. They aim to provide the financial resources and expertise needed to help businesses grow and scale their impact. Triple Jump's investment philosophy is aligned with the Sustainable Development Goals (SDGs) and other global frameworks for sustainable development.
University of Twente
Based on the provided website content, it is challenging to define a specific investment thesis or strategy for the University of Twente. The University of Twente is a research university in Enschede, Netherlands. The university's primary focus is on education and research in areas such as engineering, natural sciences, and social sciences. The website highlights various degree programs, research institutes, and collaboration opportunities, indicating an interest in fostering innovation and development in these fields. However, the information does not explicitly state a venture capital investment thesis or detail specific investment strategies. While the university facilitates research and offers collaboration opportunities with businesses, it does not directly present itself as a venture capital firm. The website showcases research institutes and encourages collaborations with external partners. These activities might lead to the development of technologies or startups that could be of interest to venture capitalists, but the university itself is not presented as an investment vehicle. The university's engagement with external parties through collaborations and research support suggests a potential interest in commercializing research outcomes. However, the website lacks specific details about investment criteria, target sectors, or financial instruments. Therefore, it is difficult to determine their investment approach without additional information.
Unknown Group
Unknown Group focuses on supporting entrepreneurs who are building solutions for a better world. They are constructing what they claim to be the largest impact campus in Europe, centered around a leading university for entrepreneurs. Their strategy includes identifying exceptional founders through initiatives like "Get in the Ring" and supporting their growth through campus facilities and university programs. They emphasize providing a physical space for founders to work, connect, and test solutions, alongside educational opportunities to further develop their businesses. The core of their investment and support strategy involves creating an ecosystem designed to foster the development of impactful and sustainable businesses.
Utrecht Health Seed Fund
Utrecht Holdings Seed Fund (UHSF) invests in science-based startups originating from or closely linked to Utrecht University (UU) and University Medical Centre Utrecht (UMCU). The fund builds upon the success of the UtrechtHealthSeed Fund (UHSF I). Their primary aim is to translate scientific research into broader societal impact by providing early-stage funding to innovative companies. They are committed to supporting ventures that address pressing challenges in healthcare and sustainability, with a focus on creating impactful solutions leveraging cutting-edge research and technologies from UU and UMCU. The fund's investment strategy reflects the research strengths of its investors, primarily focusing on Life Sciences/MedTech, Digital Innovation, and Sustainability. UHSF seeks to bridge the gap between academic research and commercial application by providing crucial seed funding to spin-offs and startups that have demonstrated a clear potential for scalability and positive impact. They are actively looking for opportunities where the innovations are deeply rooted in scientific breakthroughs. The fund invests in companies located in the Netherlands, particularly those connected to the Utrecht ecosystem. They are especially interested in innovations coming from and linked to Utrecht University and University Medical Center Utrecht. The firm intends to foster an environment where early-stage ventures can thrive by providing not only financial backing but also leveraging the vast network, knowledge base, and infrastructure of Utrecht Holdings, Utrecht University and UMCU. The goal is to advance translational science, fostering the growth of innovative businesses and contributing to economic development in the region. UHSF is managed by Utrecht Holdings, the Knowledge Transfer Office of the UU and UMCU, further cementing the alignment with the strategic research priorities and ensuring a close relationship with the source of innovative technologies. The fund seeks to create an ecosystem where academic research can be translated into tangible benefits for society and is actively involved in nurturing and mentoring companies in the early stages. They operate with a collaborative mindset, partnering with other investors and stakeholders to maximize the chances of success for their portfolio companies.
Utrecht Holdings
Utrecht Holdings bridges the gap between academic research and market application by supporting researchers from Utrecht University and UMC Utrecht. The firm provides legal, strategic, and financial backing to transform inventions—such as therapies, sustainable materials, or AI applications—into viable products or ventures, including patenting, partner matching, and early-stage funding (up to €25,000 via the *Make It Matter* voucher program).
VP Capital
VP Capital is a family office originating from Van Puijenbroek Textile, established in 1865. They have evolved into an impact-driven investor leveraging capital and network for positive change for the planet and society. Since 2019, they implemented a strategy focused on reducing negative impact and promoting positive change in sectors such as agrifood, real estate, textile, clean technology, and energy. Approximately half of their managed assets are allocated to impactful companies and innovative enterprises. Starting in 2024, VP Capital reshaped its strategy to put impact at the forefront of every decision, assessed through a financial lens. They structure their impact strategy around 3 key challenges and 6 solutions, guiding all investments based on their potential to drive these solutions and challenges. They aim to realize impact through their own organization, their capital investments and donations, and their influence as an investor by actively engaging with their investments and network on topics like biodiversity, climate change, and inequality. VP Capital's investments are long-term commitments, screened against criteria like purpose, vision, and intended impact. The due diligence process identifies financial, legal, and sustainability issues. They are actively involved with their investments, with a VP Capital team member holding a seat in a governing body in at least 75% of their assets to promote sustainability, impact, and innovation. They also maintain an exclusion list and actively work with their portfolio companies on actions to reduce negative impact. They invest across asset classes including private equity, ventures, real estate, and publicly traded businesses. Investor additionality, potential impact, and realized impact are key in their decision-making process. They support companies that drive the future of sustainability by providing not only financial support but also sharing valuable knowledge, experience, and extensive networks. VP Capital has adopted an impact-first investment strategy, inspired by Kate Raworth’s Doughnut model, to achieve a balance between social needs and planetary limits. Their investment strategy starts with impact objectives and translated into asset class targets for capital allocation to the six solutions tied to their three impact themes.
Value Factory
Value Factory Ventures investeert in startups die met innovatieve oplossingen bijdragen aan klimaatverandering en voedselzekerheid. Ze ondersteunen met kapitaal, expertise en netwerk om impactvolle, schaalbare bedrijven te ontwikkelen in AgriTech, FoodTech en duurzame bouwoplossingen, met focus op biobased materialen, regeneratieve landbouw en circulaire economie.
Voordegroei
Voordegroei provides loans to Dutch SMEs (midden- en kleinbedrijf), offering an alternative to traditional banks for companies in their 2nd and 3rd growth phases. They focus on financing companies for growth, innovation, sustainability, and international expansion. Voordegroei collaborates with capital providers such as De Goudse, OHV Vermogensbeheer, Invest-NL, and the European Investment Fund (EIF). They have launched the Fresh Dutch SME Fund and the Fresh Closed SME Fund to facilitate these financings. The Fresh Dutch SME Fund is a tradable investment fund investing in SME loans. The Fresh Closed SME Fund focuses on companies accelerating and scaling to the next phase, requiring funding for expansion, innovation, sustainability or international growth. Voordegroei aims to help entrepreneurs realize their ambitions by providing necessary financial resources through the Fresh SME Funds. The recent announcement of €40 million in additional capital from the EIF, Invest-NL, and De Goudse for the Fresh Closed SME Fund II demonstrates their commitment to supporting Dutch SMEs with a focus on growth, innovation, and sustainability. Furthermore, De Goudse's increased stake in Voordegroei from 10% to 22% signals strong confidence in the partnership and Voordegroei's approach to SME financing. They have also partnered with Nh1816 to launch a fund for intermediaries called VoordeAdviseur.
Waterland
Waterland is a European private equity firm that partners with ambitious entrepreneurs to build future-proof companies. Their investment strategy focuses on strengthening companies' competitive positions and driving sustainable growth through tailored buy-and-build strategies. With over 25 years of experience and a history of more than 1,300 investments, Waterland emphasizes a hands-on, entrepreneurial approach that combines collaboration, efficiency, responsibility, and thoughtful execution. They aim to create lasting success for their portfolio companies, leading to measurable results and attractive returns for investors. Waterland distinguishes itself by building long-lasting relationships with entrepreneurs, adding their experience to companies, and enriching their strategies to enhance resilience. They actively integrate Environmental, Social, and Governance (ESG) principles into their investment processes and portfolio, demonstrating a commitment to responsible investing and sustainable growth. Their local teams across Europe provide dedicated support to help companies achieve their growth ambitions. Waterland's investment strategy also appears to involve forming strategic partnerships between portfolio companies to facilitate expansion and market leadership, as evidenced by the strategic partnership between Palletways and Waterland, and the formation of strategic alliances like the Specialty Ingredients Distribution Group (SIDG). They actively pursue add-on acquisitions for their portfolio companies to create larger, more competitive entities, like SIDG's acquisition of i-ingredients and Deimos Group. They also occasionally exit investments through sales to larger companies or strategic partners.
Act-Vc
ACT Venture Partners invests in European deep-tech startups at the earliest stages (pre-seed and seed), providing capital (€500K–€1.5M) and strategic support to transform groundbreaking ideas into global companies. They focus on technical founders with bold visions and a track record of solving complex, foundational challenges across AI, quantum, SpaceTech, dual-use, HealthTech, and sustainability.
Brightlands Venture Partners
Brightlands Venture Partners (BVP) invests in innovative companies tackling global structural challenges across health, agrifood, and renewable chemistry systems. The firm focuses on outlier founders building scalable companies that strengthen essential societal systems. Rooted at the intersection of research, industry, and entrepreneurship, they partner with founders to turn technological breakthroughs into enduring companies. BVP provides more than just capital; they offer deep sector expertise to shape key decisions across clinical, regulatory, and commercial milestones. They aim to strike a balance between supportive and challenging, helping companies grow stronger and adding value through rigorous discussion and honest feedback to realize ambitions.
Climate-KIC
Climate-KIC positions itself as Europe's leading climate innovation agency and community. They aim to transform climate ambitions into systemic action by grounding climate action locally. Their strategy revolves around place-based transformations, learning by doing, climate entrepreneurship, and contributing to Europe 2030 missions. They facilitate collaboration within their community of over 150 global members, including universities, research institutions, cities, NGOs, and startups, to accelerate the transformation of cities, regions, and value chains for enhanced adaptation and climate resilience. Climate-KIC cultivates a critical mass to scale up both the supply and demand for climate change solutions, focusing on innovation that makes the biggest difference in transforming systems, supporting ambitious climate leaders to create change at the speed and scale required for systemic transformation. Climate-KIC leverages its network of members, comprising of bright minds, dynamic companies, strategic thinkers, and forward-thinking cities and public authorities committed to climate action and deep decarbonization through innovation. This network includes SMEs, larger corporations, start-ups, graduate students, researchers, climate experts, cities, public authorities, and NGOs. Their approach emphasizes deep collaboration between organizations and individuals within the community, uniting forces to find and implement solutions in integrated ways. Their programs encompass a wide range of initiatives, including supporting farmers towards climate-resilient food futures through FoodFutures, aiding over 100 European regions on a transformative climate resilience journey, promoting sustainable food systems in Ireland through Deep Demo Ireland, enhancing Tanzania’s climate resilience through the Adaptation Innovation Cluster, building capacity of innovation ecosystems in Latin America & the Caribbean, and accelerating European cities towards climate neutrality via NetZeroCities. They also integrate gender mainstreaming into climate innovation and empower leaders in climate innovation through the Climate-KIC Academy. Climate-KIC's impact is further amplified through community empowerment and the translation of global limits into local action, bridging the gap between global frameworks and on-the-ground implementation. Methodologies like the Butterfly Model and Reduction Roadmap are employed to couple CO2 reduction with ecosystem protection, land restoration, and a shift from extractive practices to regenerative solutions. The organization acts as a pivotal link between global climate and biodiversity limits and concrete sectoral pathways, enabling transformative change across various sectors and regions.
Exor Ventures
Exor's primary strategy appears to be building and managing great companies for the long term. They focus on creating value through active ownership and strategic management of their portfolio companies. They look for established businesses with strong market positions and growth potential, rather than solely focusing on early-stage ventures, although they do engage in some early-stage activities through affiliated entities. Their letter to shareholders emphasizes a commitment to growth and working with exceptional people. The core focus seems to be on increasing Net Asset Value (NAV) and outperforming the MSCI World Index over time. They directly invest into mature companies that are already established in their respective markets. Exor holds significant equity stakes and voting rights in a diverse portfolio of global companies. Their involvement spans various industries, including automotive (Ferrari, Stellantis, CNH, Iveco Group), healthcare (Philips, Institut Mérieux), sports (Juventus Football Club), and technology (Via Transportation). The level of economic and voting rights varies across these investments, suggesting a tailored approach to governance and influence. Exor also founded Lingotto in 2023, a long-term investment management company, and John Elkann is also a trustee of MoMA showing investment and involvement in culture. They approach investments with a long-term perspective, emphasizing sustainable growth and value creation. This is evident in their involvement with established brands like Ferrari and Philips. While they mention an "investment approach" and a detailed checklist of financial and business issues, the specific criteria for new company investments are not explicitly detailed on the website, suggesting a case-by-case evaluation process.
Forbion
Forbion is a global venture capital firm with a focus on advancing groundbreaking biotech innovations and other sustainable solutions that improve the health of people and the planet. They invest in innovative biotech companies across all stages of (bio-) pharmaceutical drug development through their Ventures and Growth strategies. In addition, they leverage their biotech expertise to address planetary health challenges through their BioEconomy fund strategy, which invests in companies developing sustainable solutions in food, agriculture, materials, and environmental technologies. They aim to select impactful investments that will positively affect the health and well-being of people and the planet while meeting financial return objectives. Forbion's investment approach is centered on building and scaling companies around compelling science and clear unmet needs. They actively source, build, and guide life sciences companies, resulting in numerous breakthrough therapies and successful exits. They manage investments across multiple fund strategies targeting different stages of company development, from pre-clinical and early clinical companies to clinical-stage drug development. Forbion operates a joint venture with BioGeneration Ventures (BGV), focusing on seed and early-stage investments, particularly in Benelux and Germany. The firm's commitment extends beyond capital commitments. They provide their portfolio companies with a collaborative and experienced investing team and advisory network, which bring expansive and profound insights into the companies and value building process. Forbion targets category-defining therapeutics and sustainable biotech solutions with global impact.
Future Food Fund
Invests in early-stage companies in Western Europe that disrupt the food & agriculture value chain, leveraging a network of industry experts and founders across farming, logistics, IT, finance, and marketing.
Gilde Healthcare
Gilde Healthcare operates with a dual mission: to invest in solutions that improve healthcare outcomes and reduce costs, and to address global challenges through investments in climate solutions. Their Healthcare funds target businesses enabling better care at a lower cost, while their Climate Solutions fund invests in energy transition, biodiversity, waste management, and pollution reduction. They aim to achieve outsized returns on impactful companies active in healthcare or climate solutions by leveraging deep industry knowledge.
Holland Capital
Holland Capital focuses on supporting growth in companies with technologies that have a substantial economic impact within the fund's term. These technologies should make existing activities more efficient or create entirely new economic activities. They also invest in innovative healthcare entrepreneurs who aim to bring a sustainable impact in healthcare; go-getters who possess the right amount of expertise in care processes and the power to implement. The firm has a clear investment strategy and aims to capitalize on multi-year trends in attractive growth markets, focusing on Healthcare and Technology. They combine successful entrepreneurship with extensive investment experience and an international network of industry leaders. Holland Capital seeks ambitious founders in scaling their company. They target products and technologies that have a substantial impact for customers in terms of efficiency, productivity, or strategic enablement. In healthcare, they look for entrepreneurs with knowledge of care processes, implementation power, and perseverance to improve the quality of care and manage healthcare expenditures. The firm has been investing responsibly and successfully in promising Dutch SMEs with growth ambitions for over 40 years. Their investment strategy involves a focus on Healthcare and Technology, providing growth financing and buy-out capital, and offering active (hands-on) support. The team strives for open, sustainable, and professional relationships with management teams, with the shared goal of achieving optimal growth.
Icos Capital
Icos Capital invests in breakthrough technologies that can deliver reduction and/or avoidance of 1 GT CO2e by 2050. They focus on Climate Tech, a rapidly growing market, and aim to achieve their target by bringing fast-growth innovators together with sector-leading corporations through their Collaborative Venturing Platform. This platform facilitates growth financing, engineering and production expertise, infrastructure, and market access. They look for ventures with sustainable profitability in line with expectations from top-tier venture capital funds, with an emphasis on research, due diligence, and working with portfolio companies to achieve financial and sustainability success. Icos Capital accelerates sustainability by investing in companies that address annual global greenhouse gas emissions. They recognize the multi-trillion market opportunity in Climate Tech and the growing number of companies with net-zero targets. The firm leverages a Collaborative Venturing Platform (CVP) to facilitate partnerships between startups and established corporations, offering growth financing, engineering expertise, production capabilities, infrastructure, and market access. The CVP program aims to accelerate sustainability. Their strategy focuses on decarbonizing to net-zero, a complex challenge they address by combining fast-growth innovators with sector-leading corporations. They are able to facilitate growth financing, engineering and production expertise, infrastructure and market access through their Collaborative Venturing Platform. Icos Capital emphasizes high-quality research and due diligence, performed by technologists, sector experts, and collaborative partners. They seek to invest in driven individuals with the potential to build best-in-class businesses and work with portfolio companies and corporate partners to ensure financial and sustainability success.
NLC - The European Healthtech Venture Builder
NLC Health Ventures is a European healthtech venture builder and early-stage investor focused on bridging the gap between scientific discoveries and market-ready solutions. Their mission is to transform patient lives by finding, building, and scaling the next generation of health innovations. They employ an entrepreneurial approach at scale, aiming to build 25 ventures per year, leveraging shared learnings and resources across their portfolio of over 100 ventures. This scaled approach increases the likelihood of bringing ideas to market and reduces risk for investors. NLC operates captive funds to scale ventures faster. NLC aims to make early-stage healthcare innovation investments accessible to both retail and institutional investors. They assess over 1500 technologies annually and have built over 110 ventures. Their expertise spans several key areas within healthcare, including cardiovascular & IGT, orthopedics & spine, therapeutics, and new markets (general healthtech). NLC emphasizes a culture of innovation and positive impact on healthcare and society. They prioritize connecting different perspectives and encouraging the exchange of ideas. They value decisiveness and optimism to effectively transform healthtech innovations. The company encourages its team to explore, question, and innovate, turning challenges into opportunities to advance global health. Their core values – Together, Open, Decisive, and Optimistic (TODO) – encapsulate their culture.
Prime Ventures
Prime Ventures invests in hypergrowth European tech companies solving real pain points with strong market fit, scalable business models, and competitive advantages. They focus on long-term partnerships, hands-on support, and leveraging their network to help founders scale globally.
QDNL Participations
QDNL Participations focuses on accelerating the quantum information age by providing funding and commercial support to early-stage quantum technology startups globally. The firm addresses the lack of specialist investors and experienced commercial support that often hinders the growth of brilliant quantum scientists and their innovations. They aim to bridge the gap between the grant-giving phase of quantum research and the 'patient capital' phase of venture investment, transforming potentially great technical ideas into investable companies. By investing in category-defining quantum technology companies, QDNL Participations seeks to become the definitive investor in the quantum technology space, driving the commercialization of quantum computing, quantum security, and other quantum applications. The firm's investment strategy centers on providing impactful business and commercial support to help technical founders organize leading talent and bring their ideas to market for the benefit of humanity. They target idea-stage founders before company incorporation, helping them assess the viability of their ideas and navigate the initial barriers to company formation and investment. Additionally, they support early-stage founders with existing companies who are seeking venture funding, mitigating common risks that investors find in research-led organizations and enhancing their governance. QDNL Participations aims to remove the worries and knowledge gaps founders face, increasing their financial and leadership confidence for success. QDNL Participations differentiates itself by providing specialized expertise in the quantum technology sector, recognizing the unique challenges and requirements of quantum companies. Their team includes quantum computing pioneers, specialist quantum VCs, and special advisors with deep expertise in AI, quantum technologies, and academic research. This expertise allows them to identify and support the next wave of global leaders in quantum technology, offering value beyond capital through strategic guidance and network access. The firm believes that a generalist or hands-off investment model is insufficient for the highly specialized quantum space.
The Sharing Group
Investing in companies that combine profitability with societal impact, particularly in energy transition, smart mobility, and urban sustainability. Focus on scalable solutions that benefit both businesses and society at large, fostering inclusive growth through shared ownership and collaborative innovation.
Volta Ventures
Volta Ventures invests in ambitious B2B SaaS companies in the Benelux region. They focus on early-stage venture capital, specifically seed and early-stage rounds. They aim to support innovative startups building scalable solutions for business customers. Their investment range is between €100k and €1M, with substantial follow-on potential. They provide support and belief in entrepreneurs to accelerate their growth, offering strategic support. They look for companies with strong product-market fit and potential for rapid scaling. Volta Ventures sees themselves as a long-term partner for their portfolio companies, offering guidance and resources to help them succeed. They actively seek out tools to enhance their own operations, indicating a data-driven approach to investing.
Aglaia
Aglaia Oncology Funds invests in early-stage oncology drug development companies with breakthrough inventions that have the potential to transform cancer treatment. They focus on selecting and maturing these early-stage ventures, de-risking them and making them attractive candidates for licensing, acquisition, or IPO. Aglaia is committed to defining the strategic directions of the companies it invests in in close collaboration with innovators and entrepreneurs. Since 2004, Aglaia has built a reputation for starting up biotech companies focused on oncology drug development. They bring hands-on experience in designing research and development plans, ranging from early screening and animal feasibility studies through clinical studies. The Aglaia team has decades of experience in cancer research and oncology drug development. Aglaia's continuous strategic and operational involvement with portfolio companies has contributed to a marked success rate in transitioning early-stage portfolio companies to clinical-stage companies. Six of the 12 companies they've invested in were founded by Aglaia.